FDA clears Alabama university's depression device

06/9/2010 | American City Business Journals

The FDA has given the green light to the University of Alabama, Birmingham, to use its Repetitive Transcranial Magnetic Stimulation device for the treatment of patients who have failed to respond to antidepressant drugs. The rTMS device works by delivering MRI-strength magnetic pulses to the brain.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA